iPS cell modeling of best disease: Insights into the pathophysiology of an inherited macular degeneration

Human Molecular Genetics

Volumn 22, Issue 3, 2013, Pages 593-607

  Singh, Ruchira ^a   Shen, Wei ^a   Kuai, David ^a   Martin, Jessica M ^a   Guo, Xiangrong ^a   Smith, Molly A ^a   Perez, Enio T ^a   Phillips, M Joseph ^a   Simonett, Joseph M ^a   Wallace, Kyle A ^a   Verhoeven, Amelia D ^a   Capowski, Elizabeth E ^a   Zhang, Xiaoqing ^a   Yin, Yingnan ^a   Halbach, Patrick J ^b   Fishman, Gerald A ^c   Wright, Lynda S ^a   Pattnaik, Bikash R ^b   Gamm, David M ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHODOPSIN;

ARTICLE; AUTOFLUORESCENCE; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FLUID FLOW; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; PHOTORECEPTOR OUTER SEGMENT; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA MACULA VITELLIFORM DEGENERATION;

ANIMALS; CALCIUM; CATTLE; CELL DIFFERENTIATION; CELL LINE; CHLORIDE CHANNELS; EYE PROTEINS; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INDUCED PLURIPOTENT STEM CELLS; MACULA LUTEA; MICROSCOPY, ELECTRON, TRANSMISSION; OXIDATIVE STRESS; PHAGOCYTOSIS; RETINAL PHOTORECEPTOR CELL OUTER SEGMENT; RETINAL PIGMENT EPITHELIUM; VITELLIFORM MACULAR DYSTROPHY;

IPS;

EID: 84872390953     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds469     Document Type: Article

References (60)

1. Ebert, A.D., Yu, J., Rose, F.F. Jr, Mattis, V.B., Lorson, C.L., Thomson, J.A. and Svendsen, C.N. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 457, 277-280.
2. Gamm, D.M. and Meyer, J.S. (2010) Directed differentiation of human induced pluripotent stem cells: a retina perspective. Regen. Med., 5, 315-317.
3. Park, I.H., Lerou, P.H., Zhao, R., Huo, H. and Daley, G.Q. (2008) Generation of human-induced pluripotent stem cells. Nat. Protoc., 3, 1180-1186.
4. Marchetto, M.C. and Gage, F.H. Modeling brain disease in a dish: really? Cell Stem Cell, 10, 642-645.
5. Meyer, J.S., Howden, S.E., Wallace, K.A., Verhoeven, A.D., Wright, L.S., Capowski, E.E., Pinilla, I., Martin, J.M., Tian, S., Stewart, R. et al. (2011) Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells, 29, 1206-1218.
6. Tiscornia, G., Vivas, E.L. and Izpisua Belmonte, J.C. Diseases in a dish: modeling human genetic disorders using induced pluripotent cells. Nat. Med., 17, 1570-1576.
7. Israel, M.A., Yuan, S.H., Bardy, C., Reyna, S.M., Mu, Y., Herrera, C., Hefferan, M.P., Van Gorp, S., Nazor, K.L., Boscolo, F.S. et al. (2012) Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature, 482, 216-220.
8. Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H. et al. (2011) Modelling the long QT syndrome with induced pluripotent stem cells. Nature, 471, 225-229.
9. Maehr, R., Chen, S., Snitow, M., Ludwig, T., Yagasaki, L., Goland, R., Leibel, R.L. and Melton, D.A. (2009) Generation of pluripotent stem cells from patients with type 1 diabetes. Proc. Natl Acad. Sci. U S A, 106, 15768-15773.
10. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M.W., Cowan, C., Hochedlinger, K. and Daley, G.Q. (2008) Disease-specific induced pluripotent stem cells. Cell, 134, 877-886.
11. Howden, S.E., Gore, A., Li, Z., Fung, H.L., Nisler, B.S., Nie, J., Chen, G., McIntosh, B.E., Gulbranson, D.R., Diol, N.R. et al. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc. Natl Acad. Sci. U S A., 108, 6537-6542.
12. Kokkinaki, M., Sahibzada, N. and Golestaneh, N. (2011) Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells, 29, 825-835.
13. Phillips, M.J., Wallace, K.A., Dickerson, S.J., Miller, M.J., Verhoeven, A.D., Martin, J.M., Wright, L.S., Shen, W., Capowski, E.E., Percin, E.F. et al. (2012) Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest. Ophthalmol. Vis. Sci., 53, 2007-2019.
14. Carr, A.J., Vugler, A.A., Hikita, S.T., Lawrence, J.M., Gias, C., Chen, L.L., Buchholz, D.E., Ahmado, A., Semo, M., Smart, M.J. et al.. (2009) Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS ONE, 4, e8152.
15. Brennand, K.J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D. et al. (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature, 473, 221-225.
16. Meyer, J.S., Shearer, R.L., Capowski, E.E., Wright, L.S., Wallace, K.A., McMillan, E.L., Zhang, S.C. and Gamm, D.M. (2009) Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc. Natl Acad. Sci. U S A, 106, 16698-16703.
17. Rowland, T.J., Blaschke, A.J., Buchholz, D.E., Hikita, S.T., Johnson, L.V. and Clegg, D.O. (2012) Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins. J. Tissue Eng. Regen. Med. [Epub ahead of print]
18. Liao, J.L., Yu, J., Huang, K., Hu, J., Diemer, T., Ma, Z., Dvash, T., Yang, X.J., Travis, G.H., Williams, D.S. et al. Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells. Hum. Mol. Genet., 19, 4229-4238.
19. Buchholz, D.E., Hikita, S.T., Rowland, T.J., Friedrich, A.M., Hinman, C.R., Johnson, L.V. and Clegg, D.O. (2009) Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells, 27, 2427-2434.
20. Maminishkis, A., Chen, S., Jalickee, S., Banzon, T., Shi, G., Wang, F.E., Ehalt, T., Hammer, J.A. and Miller, S.S. (2006) Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest. Ophthalmol. Vis. Sci., 47, 3612-3624.
21. Schwartz, S.D., Hubschman, J.P., Heilwell, G., Franco-Cardenas, V., Pan, C.K., Ostrick, R.M., Mickunas, E., Gay, R., Klimanskaya, I. and Lanza, R. (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet, 379, 713-720.
22. Blodi, C.F. and Stone, E.M. (1990) Best's vitelliform dystrophy. Ophthalmic Paediatr. Genet., 11, 49-59.
23. Nordstrom, S. and Barkman, Y. (1977) Hereditary maculardegeneration (HMD) in 246 cases traced to one gene-source in central Sweden. Hereditas, 84, 163-176.
24. Boon, C.J., Klevering, B.J., Leroy, B.P., Hoyng, C.B., Keunen, J.E. and den Hollander, A.I. (2009) The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog. Retin. Eye Res., 28, 187-205.
25. Mohler, C.W. and Fine, S.L. (1981) Long-term evaluation of patients with Best's vitelliform dystrophy. Ophthalmology, 88, 688-692.
26. Xiao, Q., Hartzell, H.C. and Yu, K. (2010) Bestrophins and retinopathies. Pflugers. Arch., 460, 559-569.
27. Bakall, B., Radu, R.A., Stanton, J.B., Burke, J.M., McKay, B.S., Wadelius, C., Mullins, R.F., Stone, E.M., Travis, G.H. and Marmorstein, A.D. (2007) Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). Exp. Eye Res., 85, 34-43.
28. Fischmeister, R. and Hartzell, H.C. (2005) Volume sensitivity of the bestrophin family of chloride channels. J. Physiol., 562, 477-491.
29. Petrukhin, K., Koisti, M.J., Bakall, B., Li, W., Xie, G., Marknell, T., Sandgren, O., Forsman, K., Holmgren, G., Andreasson, S. et al. (1998) Identification of the gene responsible for Best macular dystrophy. Nat. Genet., 19, 241-247.
30. Hartzell, H.C., Qu, Z., Yu, K., Xiao, Q. and Chien, L.T. (2008) Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies. Physiol. Rev., 88, 639-672.
31. Marmorstein, A.D., Marmorstein, L.Y., Rayborn, M., Wang, X., Hollyfield, J.G. and Petrukhin, K. (2000) Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc. Natl Acad. Sci. U S A, 97, 12758-12763.
32. Rosenthal, R., Bakall, B., Kinnick, T., Peachey, N., Wimmers, S., Wadelius, C., Marmorstein, A. and Strauss, O. (2006) Expression of bestrophin-1, the product of the VMD2 gene, modulates voltage-dependent Ca2+ channels in retinal pigment epithelial cells. FASEB J., 20, 178-180.
33. Sun, H., Tsunenari, T., Yau, K.W. and Nathans, J. (2002) The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc. Natl Acad. Sci. U S A, 99, 4008-4013.
34. Qu, Z. and Hartzell, H.C. (2008) Bestrophin Cl- channels are highly permeable to HCO3. Am. J. Physiol. Cell Physiol., 294, C1371-C1377.
35. Barro-Soria, R., Aldehni, F., Almaca, J., Witzgall, R., Schreiber, R. and Kunzelmann, K. (2010) ER-localized bestrophin 1 activates Ca2+-dependent ion channels TMEM16A and SK4 possibly by acting as a counterion channel. Pflugers Arch., 459, 485-497.
36. Neussert, R., Muller, C., Milenkovic, V.M. and Strauss, O. (2010) The presence of bestrophin-1 modulates the Ca2+ recruitment from Ca2+ stores in the ER. Pflugers Arch., 460, 163-175.
37. Marmorstein, A.D., Cross, H.E. and Peachey, N.S. (2009) Functional roles of bestrophins in ocular epithelia. Prog. Retin. Eye. Res., 28, 206-226.
38. Guziewicz, K.E., Zangerl, B., Lindauer, S.J., Mullins, R.F., Sandmeyer, L.S., Grahn, B.H., Stone, E.M., Acland, G.M. and Aguirre, G.D. (2007) Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model for best disease. Invest. Ophthalmol. Vis. Sci., 48, 1959-1967.
39. Sonoda, S., Spee, C., Barron, E., Ryan, S.J., Kannan, R. and Hinton, D.R. (2009) A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells. Nat. Protoc., 4, 662-673.
40. Mircheff, A.K., Miller, S.S., Farber, D.B., Bradley, M.E., O'Day, W.T. and Bok, D. (1990) Isolation and provisional identification of plasma membrane populations from cultured human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci., 31, 863-878.
41. Peterson, W.M., Meggyesy, C., Yu, K. and Miller, S.S. (1997) Extracellular ATP activates calcium signaling, ion, and fluid transport in retinal pigment epithelium. J. Neurosci., 17, 2324-2337.
42. Plafker, S.M. (2010) Oxidative stress and the ubiquitin proteolytic system in age-related macular degeneration. Adv. Exp. Med. Biol., 664, 447-456.
43. Barot, M., Gokulgandhi, M.R. and Mitra, A.K. (2011) Mitochondrial dysfunction in retinal diseases. Curr. Eye Res., 36, 1069-1077.
44. Okamoto, S. and Takahashi, M. (2011) Induction of retinal pigment epithelial cells from monkey iPS cells. Invest. Ophthalmol Vis. Sci., 52, 8785-8790.
45. Nunes, P. and Demaurex, N. (2010) The role of calcium signaling in phagocytosis. J. Leukoc. Biol., 88, 57-68.
46. Marmorstein, L.Y., Wu, J., McLaughlin, P., Yocom, J., Karl, M.O., Neussert, R., Wimmers, S., Stanton, J.B., Gregg, R.G., Strauss, O. et al. (2006) The light peak of the electroretinogram is dependent on voltage-gated calcium channels and antagonized by bestrophin (best-1). J. Gen. Physiol., 127, 577-589.
47. Fishman, G.A., Baca, W., Alexander, K.R., Derlacki, D.J., Glenn, A.M. and Viana, M. (1993) Visual acuity in patients with best vitelliform macular dystrophy. Ophthalmology, 100, 1665-1670.
48. Ponjavic, V., Eksandh, L., Andreasson, S., Sjostrom, K., Bakall, B., Ingvast, S., Wadelius, C. and Ehinger, B. (1999) Clinical expression of Best's vitelliform macular dystrophy in Swedish families with mutations in the bestrophin gene. Ophthalmic. Genet., 20, 251-257.
49. Mullins, R.F., Oh, K.T., Heffron, E., Hageman, G.S. and Stone, E.M. (2005) Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation. Arch. Ophthalmol., 123, 1588-1594.
50. Frangieh, G.T., Green, W.R. and Fine, S.L. (1982) A histopathologic study of Best's macular dystrophy. Arch. Ophthalmol., 100, 1115-1121.
51. Vugler, A., Carr, A.J., Lawrence, J., Chen, L.L., Burrell, K., Wright, A., Lundh, P., Semo, M., Ahmado, A., Gias, C. et al. (2008) Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp. Neurol., 214, 347-361.
52. Smith, R.T., Chan, J.K., Busuoic, M., Sivagnanavel, V., Bird, A.C. and Chong, N.V. (2006) Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 47, 5495-5504.
53. Schmitz-Valckenberg, S., Bultmann, S., Dreyhaupt, J., Bindewald, A., Holz, F.G. and Rohrschneider, K. (2004) Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 45, 4470-4476.
54. Chen, H., Lukas, T.J., Du, N., Suyeoka, G. and Neufeld, A.H. (2009) Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity. Invest. Ophthalmol. Vis. Sci., 50, 1895-1902.
55. Chowers, I., Wong, R., Dentchev, T., Farkas, R.H., Iacovelli, J., Gunatilaka, T.L., Medeiros, N.E., Presley, J.B., Campochiaro, P.A., Curcio, C.A. et al. (2006) The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 47, 2135-2140.
56. Weleber, R.G., Carr, R.E., Murphey, W.H., Sheffield, V.C. and Stone, E.M. (1993) Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. Arch. Ophthalmol., 111, 1531-1542.
57. Nakazawa, M., Naoi, N., Wada, Y., Nakazaki, S., Maruiwa, F., Sawada, A. and Tamai, M. (1996) Autosomal dominant cone-rod dystrophy associated with a Val200Glu mutation of the peripherin/RDS gene. Retina, 16, 405-410.
58. Sparrow, J.R. and Boulton, M. (2005) RPE lipofuscin and its role in retinal pathobiology. Exp. Eye Res., 80, 595-606.
59. Stamer,W.D., Bok, D.,Hu, J., Jaffe,G.J. and McKay, B.S. (2003) Aquaporin-1 channels in human retinal pigment epithelium: role in transepithelial water movement. Invest. Ophthalmol. Vis. Sci., 44, 2803-2808.
60. Capowski, E.E., Schneider, B.L., Ebert, A.D., Seehus, C.R., Szulc, J., Zufferey, R., Aebischer, P. and Svendsen, C.N. (2007) Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. J. Neurosci. Methods, 163, 338-349.